A recent discovery has found a previously unexamined immune reaction in patients with lupus, a fluctuating disease that causes inflammation and other problems in a variety of organ systems. The researchers observed that the lupus patients in their study have…
Bioengineer.org Subject of Research: Chemogenetic and pharmacological activation of the oxytocin system in a rat model of adjuvant arthritis Article Title: Chemogenetic and pharmacological activation of the oxytocin system ameliorates adjuvant arthritis in rats News Source: Cassandra Pierce. (November…
Medicare can be confusing! Join us for a free educational seminar to get you up to speed on what Medicare covers, what it... New to Medicare? Leaving Employer Soon? Turning 65? Come learn about your options? Medicare can be confusing! Join…
Newswise — LOS ANGELES (Nov. 5, 2026) -- Cedars-Sinai physicians and scientists from the Kao Autoimmunity Institute will present new research on autoimmune and rheumatologic diseases at ACR Convergence 2026, the American College of Rheumatology (ACR) annual scientific meeting, Nov. 6-11 in Orlando, Florida. Presentations will…
In this clip, Amanda L. Piquet, MD, discusses the significant unmet treatment needs facing patients with stiff person syndrome (SPS), a debilitating autoimmune neurologic disease. Drawing on findings from the phase 2 KYSA-8 study evaluating CD19-directed CAR T-cell therapy mivocabtagene autoleucel (miv-cel),…
In this segment, Dr. Mark Dailey, Dr. Caron A. Jacobson, and NP Stefanie Sigmund introduce the challenges of coordinating chimeric antigen receptor (CAR) T-cell therapy for patients with diffuse large B-cell lymphoma (DLBCL), particularly those who must travel long distances to…
- In this segment, Dr. Caron A. Jacobson discusses strategies to streamline referrals for chimeric antigen receptor (CAR) T-cell therapy in patients with diffuse large B-cell lymphoma (DLBCL). She emphasizes the importance of understanding how CAR T-cell services are organized at the…
A case report describes how calcineurin inhibitor-free, mTOR-based immunosuppression enabled successful CD19 CAR T-cell therapy in a kidney-pancreas transplant recipient with relapsed post-transplant lymphoproliferative disorder.
Receive 4 digital issues and online access to articles Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. Available from www.cochrane.org/handbook. Figueredo…
Immunologists and rheumatologists are both experts on the human immune system. Pediatric immunologists diagnose and treat congenital causes of primary immune deficiencies and offer bone marrow transplant for cure of certain immune deficiencies such SCID. Rheumatologists manage rheumatic diseases, most…
Arthritis, lupus, vasculitis, biologics, and immune‑modulating therapies.
An article joins this feed when it matches these terms. Each one is also a search of its own.